Ep 28: Unlocking the Secrets of Cancer: The Role of Omics
Release Date: 06/02/2025
Ep 51: AI Can’t Fix Virtual Care’s 70% Lab Problem
Boombostic Health
Virtual care is scaling. AI is everywhere. But when lab completion falls from ~70% in-clinic to ~30% in virtual care, the whole model breaks. Virtual Care Without Labs Is Just Zoom - Even with AI. In this Boombostic Health in the Wild episode from HLTH 2025, Bradley Bostic sits down with Maitham Dib, founder of Junction, to unpack the "real" bottleneck: turning lab orders into lab results. They dig into how Junction: * White-labels lab infrastructure so any virtual or hybrid care model can deploy labs across all 50 states * Uses data from ~3.4 million lab...
info_outline
Ep 50: 95% of Care From Home: The Virtual Model Changing Healthcare
Boombostic Health
Virtual care isn’t a feature. It’s the future care model nobody in healthcare wants to admit is already here. At HLTH 2025, we sat down with Michael Dalton, CEO and founder of Ovatient, to unpack the real story behind why rural and urban patients alike are falling through the cracks and how Ovatient built the first truly integrated virtual multi-specialty practice on Epic. This conversation exposes three uncomfortable truths in healthcare: Access is still broken. Millions delay care because transportation, work schedules, stigma, or geography get in the way. Telemedicine wasn’t...
info_outline
Ep 49: The Real Healthcare Disruption Isn’t AI - It’s Your DNA
Boombostic Health
AI will accelerate healthcare — but genomics will rewrite it. The minute DNA drives care decisions for everyone, the current system becomes obsolete. Gene by Gene quietly runs one of the most advanced, high-throughput genomics labs in the world — powering platforms like MyHeritage and rapidly transforming clinical medicine, oncology, pharmacogenomics, and ancestry. This conversation explores what happens when every person leaves the hospital with a genomic passport — a lifelong DNA profile they own, control, and use to prevent disease before it begins. This is preventive medicine...
info_outline
Ep 48: Time to Treatment Accelerating the Connection to Care
Boombostic Health
Pharma Isn’t Broken — Access Is ixlayer x Sanofi Ventures @ HLTH 2025 Patients don’t suffer because we lack medical innovation — they suffer because it takes too long to access it. 🚀 Why This Matters Patients today are consumers — they expect speed, personalization, and access. Pharma, technology, and venture capital are aligning to deliver it. The future of healthcare is collaborative, data-driven, and patient-first. Live from HLTH 2025 in the Diagnostic Zone, we dig into the real barriers between patients and lifesaving therapies. This episode covers: How digital...
info_outline
Ep 47: Fixing Prescription Costs with E-Prescribing and Transparency
Boombostic Health
Prescription costs are broken — and patients are the ones paying the price. In this episode of Boombostic Health, host Bradley Bostic sits down with Lathe Bigler of First Data Bank to unpack why e-prescribing hasn’t evolved in decades, how opaque pricing keeps patients in the dark, and why the next wave of pharmacy network innovation could flip the power dynamic back to patients. 💡 What We Cover: Why patients are frustrated with rising prescription costs How transparency empowers patients with real choices What most people don’t know about paying cash for prescriptions How...
info_outline
Ep 46: The Conversations You Need to Hear About AI in Healthcare
Boombostic Health
Summary This conversation explores the transformative potential of AI in healthcare, emphasizing the importance of agentic AI, interoperability, and the need for a shift in medical education. The speakers discuss the challenges and opportunities presented by AI technologies, the necessity of upskilling healthcare professionals, and the economic models that must evolve to support these changes. They highlight the importance of viewing information as an asset and the role of AI in enabling personalized, longitudinal care for patients. Takeaways There's always a new challenge to overcome...
info_outline
Ep 45: Building an AI-Ready Future for Healthcare
Boombostic Health
Summary The business of healthcare is broken — but intelligence might finally fix it. In this episode of Boombostic Health, Bradley Bostic and Jason Wenell reveal how to build an AI-ready healthcare system that learns, adapts, and delivers real value. Jason shares his three-layer framework — upskill people, automate workflows, and build AI-native systems that think. Discover how AI is becoming the engine behind value-based care and what it means for the future of healthcare innovation. Takeaways AI is revolutionizing healthcare and other industries. Value-based care relies heavily on data...
info_outline
Ep 44: Rethinking Telemedicine - How Digital Healthcare Can Bend the $5 Trillion Cost Curve
Boombostic Health
Summary In this conversation, Craig Hittle discusses the evolving nature of telemedicine, emphasizing that it should not be viewed merely as a transactional service. Instead, he advocates for a model that fosters long-term relationships between patients and healthcare providers, enhancing the overall quality of care delivered through digital platforms. Takeaways Telemedicine is often misunderstood as purely transactional. The goal of telemedicine should be to build relationships. Long-term relationships with providers can improve patient care. Telemedicine can enhance accessibility to...
info_outline
Ep 43: The $528B Fix Healthcare Can't Ignore: Why Are We Still Guessing Meds?
Boombostic Health
Every year in the U.S., 275,000 people die because of medication mismanagement — a failure that drains $528 billion annually from our $5 trillion healthcare system. It’s healthcare’s deadly hidden failure. That’s where DecisionRx comes in. Their coined Medication Therapy Optimization (MTO) approach goes far beyond Pharmacogenetics (PGx), combining AI-powered insights with pharmacist-led care to stop the guesswork, lower risk, and deliver results at scale. In this episode, host Bradley Bostic sits down with Mike Tilton, Chief Growth Officer at DecisionRx, to unpack the problem and...
info_outline
Ep 42: MedTechs's 10X Advantage - How Real-World Data Expands Device Impact
Boombostic Health
Summary Pre-market clinical trials are essential — but they don’t reflect how devices truly perform once they’re in the real world. In this episode of Boombostic Health, host Bradley Bostic sits down with Dr. Amelia Hufford, Co-Founder and SVP of Clinical and Regulatory Science at 3Aware, to unpack why real-world data (RWD) is critical to the survival of medical devices — and why mindset, not science, may be the biggest barrier holding MedTech back. Amelia shares her 20+ year journey in scientific and clinical research, including a decade in MedTech leading regulatory and clinical...
info_outlineSummary
In this episode of Boombostic Health, Bradley Bostic interviews Dustin Suntheimer, Director of Commercial Operations in diagnostics, to discuss the advancements in oncology testing and the impact of genetic profiling on cancer treatment.
They explore the evolution of cancer diagnostics, the significance of omics, and the role of advanced genetic testing in personalizing treatment plans. The conversation also touches on the accessibility of these tests across different demographics and the future of cancer care, emphasizing the importance of collaboration between healthcare providers and laboratories.
Watch full episode on YouTube here
Takeaways
- The state of oncology testing has significantly improved over the years.
- Advanced molecular assays can lead to better patient outcomes.
- Digital pathology allows for remote examination of tissue samples.
- Genetic testing can help eliminate ineffective treatments.
- Molecular profiling is essential for personalized cancer therapy.
- Omics encompasses various fields that enhance our understanding of biology.
- Precision medicine tailors treatment based on individual genetic profiles.
- Genetic testing should be accessible to all patients, regardless of socioeconomic status.
- Healthcare providers must be aware of genetic testing guidelines.
- Collaboration between physicians and laboratories is crucial for patient care.
Chapters
00:00 Introduction to Oncology Testing and Its Evolution
03:01 Understanding Anatomic Pathology and Molecular Testing
06:00 The Importance of Genetic Profiling in Cancer Treatment
08:55 The Role of Omics in Cancer Diagnostics
11:52 Advanced Technologies in Cancer Testing
14:54 The Impact of Genetic Testing on Preventative Care
17:49 Tracking Cancer Recurrence with Advanced Testing
21:00 The Importance of Family History in Cancer Risk
24:05 Guidelines for Genetic Testing and Preventative Measures
26:55 Healthcare Innovation and the Future of Cancer Treatment
29:55 The Socioeconomic Factors in Accessing Genetic Testing
33:08 Conclusion and Future Directions in Oncology